India Healthtech Fund

The India Healthtech Fund operates within the broader IndiaAI ecosystem and is positioned as a dedicated impact vehicle driving AI innovation for healthcare accessibility, including clinical screening tools, diagnostics, and population-level health applications. The fund’s mandate spans pre-seed, seed, and Series A, with cheque sizes that have not been publicly disclosed and which founders should expect to vary by application track. For founders, this fund is best understood as a mission-aligned catalytic investor that combines capital with regulatory and government access, particularly useful for AI clinical products targeting public health deployment through MOHFW, ABDM, or state government channels. The right founder profile is an Indian or India-deploying team building AI/ML clinical tools (radiology, pathology, ophthalmology screening), telemedicine, or population health platforms with a credible plan to deploy at scale through public or large private health systems. Founders running consumer wellness, asset-heavy clinic chains, or international-only plays should not approach. Entry path is via the IndiaAI portal, the MeitY innovation programs, or warm introductions from co-investing seed funds (Pi Ventures, Stellaris, IvyCap) that frequently flow deals through the IndiaAI rail. In the pitch, lead with clinical validation evidence, regulatory pathway through CDSCO, ABDM and ABHA integration, and a concrete plan to deploy at population scale rather than boutique pilots. Caveats: as an impact-aligned and government-affiliated vehicle, the fund’s processes can be procedurally heavy, term sheets may include impact reporting and deployment commitments, and timelines can be longer than purely commercial venture funds. Public footprint is still developing and cheque sizes are uneven, so founders should request a current deal sheet, programme calendar, and cheque guidance during initial diligence to calibrate expectations.